Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Emapalumab therapy for hemophagocytic lymphohistiocytosis prior to reduced-intensity transplantation improves chimerism

Bethany Verkamp, Sonata Jodele, Anthony Sabulski, Rebecca A Marsh, Pearce Kieser, Michael B. Jordan

Blood blood.2024025977.

https://doi.org/10.1182/blood.2024025977

Published: 2024

Includes: Supplemental data

Journal Articles

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Jennifer W. Leiding, Danielle E. Arnold, Suhag Parikh, Brent Logan, Rebecca A. Marsh, Linda M. Griffith, Ruizhe Wu, Sharon Kidd, Kanwaldeep Mallhi, Deepak Chellapandian, Stephanie J. Si Lim, Eyal Grunebaum, E. Liana Falcone, Luis Murguia-Favela, Debbi Grossman, Vinod K. Prasad, Jennifer R. Heimall, Fabien Touzot, Lauri M. Burroughs, Jack Bleesing, Neena Kapoor, Jasmeen Dara, Olatundun Williams, Malika Kapadia, Benjamin R. Oshrine, Jeffrey J. Bednarski, Ahmad Rayes, Hey Chong, Geoffrey D. E. Cuvelier, Lisa R. Forbes Satter, Caridad Martinez, Mark T. Vander Lugt, Lolie C. Yu, Shanmuganathan Chandrakasan, Avni Joshi, Susan E. Prockop, Blachy J. Dávila Saldaña, Victor Aquino, Larisa A. Broglie, Christen L. Ebens, Lisa M. Madden, Kenneth DeSantes, Jordan Milner, Hemalatha G. Rangarajan, Ami J. Shah, Alfred P. Gillio, Alan P. Knutsen, Holly K. Miller, Theodore B. Moore, Pamela Graham, Andrea Bauchat, Nancy J. Bunin, Pierre Teira, Aleksandra Petrovic, Sharat Chandra, Hisham Abdel-Azim, Morna J. Dorsey, Olga Birbrayer, Morton J. Cowan, Christopher C. Dvorak, Elie Haddad, Donald B. Kohn, Luigi D. Notarangelo, Sung-Yun Pai, Jennifer M. Puck, Michael A. Pulsipher, Troy R. Torgerson, Harry L. Malech, Elizabeth M. Kang

Blood (2023) 142 (24): 2105–2118.

https://doi.org/10.1182/blood.2022019586

Published: 2023

Includes: Supplemental data

Journal Articles

Long-Term Outcome of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1) Using an Enhancer-Deleted Self-Inactivating Gammaretroviral Vector

Blood (2022) 140 (Supplement 1): 10643–10645.

https://doi.org/10.1182/blood-2022-159768

Published: 2022

Journal Articles

Quercetin ameliorates XIAP deficiency–associated hyperinflammation

Samuel C. C. Chiang, Erika Owsley, Neelam Panchal, Vijaya Chaturvedi, Catherine E. Terrell, Michael B. Jordan, Parinda A. Mehta, Stella M. Davies, Nagako Akeno, Claire Booth, Rebecca A. Marsh

Blood (2022) 140 (7): 706–715.

https://doi.org/10.1182/blood.2021014335

Published: 2022

Includes: Supplemental data

Journal Articles

Peri-Transplant Alemtuzumab Levels Predict Risk of Secondary Graft Failure and Inversely Impact CXCL9 Levels after RIC HCT (A Correlative Biology Study to BMT-CTN 1204 RICHI)

Ashley V Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A. Pulsipher, Mary Eapen, Jim A. Connelly, Catherine M. Bollard, Sung-Yun Pai, Christine N. Duncan, Leslie S Kean, K. Scott Baker, Lauri S Burroughs, Jeffrey R. Andolina, Michael B Jordan, Tsz-Kwong Man, Carl E. Allen, Rebecca A. Marsh

Blood (2021) 138 (Supplement 1): 748.

https://doi.org/10.1182/blood-2021-145629

Published: 2021

Journal Articles

T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis

Vandana Chaturvedi, Rebecca A. Marsh, Adi Zoref-Lorenz, Erika Owsley, Vijaya Chaturvedi, Trung C. Nguyen, Jordana R. Goldman, Michael M. Henry, Jay N. Greenberg, Stephan Ladisch, Michelle L. Hermiston, Michael Jeng, Ahmed Naqvi, Carl E. Allen, Hector R. Wong, Michael B. Jordan

Blood (2021) 137 (17): 2337–2346.

https://doi.org/10.1182/blood.2020009499

Published: 2021

Includes: Supplemental data

Journal Articles

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

Rebecca A. Marsh, Soyoung Kim, Kyle Hebert, Christopher C. Dvorak, MD, Victor Aquino, MD, K. Scott Scott Baker, MD MS, Deepak Chellapandian, MD, Blachy Davila, MD, Christine Duncan, MD, Michael J. Eckrich, MD MPH, George E. Georges, MD, Timothy S. Olson, MD PhD, Michael A Pulsipher, MD, Shalini Shenoy, MD, Elizabeth Stenger, MD, Mark Vander Lugt, MD, Lolie C. Yu, MD, Andrew Gennery, MD, Mary Eapen, MBBS, MS

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-139930

Published: 2020

Journal Articles

A Multi-Center Case Series, Systematic Review and Meta-Analysis of Neonatal Hemophagocytic Lymphohistiocytosis

Christen L. Ebens, MDMPH, Adam S DuVall, MD, Todd E. DeFor, MS, Marketa T. Dimitrov, MD, David Frame, Michael A. Briones, Michael Grimley, MD, Sarita Joshi, MBBS,MD, Rebecca A. Marsh, Evan Shereck, MD, Mark Vander Lugt, MD, James A. Connelly, MD, Kelly J. Walkovich, MD

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-142895

Published: 2020

Journal Articles

Pediatric hemophagocytic lymphohistiocytosis

Scott W. Canna, Rebecca A. Marsh

Blood (2020) 135 (16): 1332–1343.

https://doi.org/10.1182/blood.2019000936

Published: 2020

Journal Articles

Neutropenia Is an Under-Recognized Finding in Pediatric Primary Immunodeficiency Diseases: An Analysis of the United States Immunodeficiency Network Registry

Thomas F. Michniacki, MD, Kelly J. Walkovich, MD, Julie Sturza, MPH, Lauren E. Merz, BA, James Connelly, MD, Rebecca A. Marsh, David C Dale, MD, Elizabeth Garabedian, RN, MS

Blood (2018) 132 (Supplement 1): 3685.

https://doi.org/10.1182/blood-2018-99-113199

Published: 2018

Journal Articles

Treatment Dilemmas in Asymptomatic Children with Primary Haemophagocytic Lymphohistiocytosis

Blood (2017) 130 (Supplement 1): 3564.

https://doi.org/10.1182/blood.V130.Suppl_1.3564.3564

Published: 2017

Journal Articles

HIF1A Is a Critical Downstream Mediator for Hemophagocytic Lymphohistiocytosis

Blood (2017) 130 (Supplement 1): 3565.

https://doi.org/10.1182/blood.V130.Suppl_1.3565.3565

Published: 2017

Journal Articles

Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH

Tamar S. Rubin, Kejian Zhang, Carrie Gifford, Adam Lane, Sharon Choo, Jack J. Bleesing, Rebecca A. Marsh

Blood (2017) 129 (22): 2993–2999.

https://doi.org/10.1182/blood-2016-12-753830

Published: 2017

Includes: Supplemental data

Journal Articles

Precision Dosing of Alemtuzumab: Population Pharmacokinetic Modeling in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Non-Malignant Diseases

Tsuyoshi Fukuda, PhD, Chie Emoto, PhD, Rebecca A Marsh, MD, Lisa Neumeier, BS, Alexander A. Vinks, PharmD, PhD, Parinda A Mehta, MD

Blood (2016) 128 (22): 2203.

https://doi.org/10.1182/blood.V128.22.2203.2203

Published: 2016

Journal Articles

JAK1/2 Inhibition As a Salvage Therapy for Steroid Refractory Acute and Chronic Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients

Pooja Khandelwal, MD, Ashley Teusink-Cross, PharmD, Adam S. Nelson, MBBS, Christopher E. Dandoy, MD, Javier A. El-Bietar, MD, Rebecca A Marsh, MD, Ashish R Kumar, MBBS, PhD, Michael S Grimley, MD, Sonata Jodele, MD, Stella M Davies, MBBS, PhD, Kasiani C. Myers, MD

Blood (2016) 128 (22): 4568.

https://doi.org/10.1182/blood.V128.22.4568.4568

Published: 2016

Journal Articles

Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT

Rebecca A. Marsh, Adam Lane, Parinda A. Mehta, Lisa Neumeier, Sonata Jodele, Stella M. Davies, Alexandra H. Filipovich

Blood (2016) 127 (4): 503–512.

https://doi.org/10.1182/blood-2015-07-659672

Published: 2016

Journal Articles

Accuracy of flow cytometric perforin screening for detecting patients with FHL due to PRF1 mutations

Manar Abdalgani, Alexandra H. Filipovich, Sharon Choo, Kejian Zhang, Carrie Gifford, Joyce Villanueva, Jack J. Bleesing, Rebecca A. Marsh

Blood (2015) 126 (15): 1858–1860.

https://doi.org/10.1182/blood-2015-06-648659

Published: 2015

Includes: Supplemental data

Journal Articles

Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes

Blood (2013) 121 (6): 877–883.

https://doi.org/10.1182/blood-2012-06-432500

Published: 2013

Journal Articles

Hypomorphic mutations in PRF1 , MUNC13-4 , and STXBP2 are associated with adult-onset familial HLH

Kejian Zhang, Michael B. Jordan, Rebecca A. Marsh, Judith A. Johnson, Diane Kissell, Jarek Meller, Joyce Villanueva, Kimberly A. Risma, Qian Wei, Peter S. Klein, Alexandra H. Filipovich

Blood (2011) 118 (22): 5794–5798.

https://doi.org/10.1182/blood-2011-07-370148

Published: 2011

Journal Articles

Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation

Rebecca A. Marsh, Gretchen Vaughn, Mi-Ok Kim, Dandan Li, Sonata Jodele, Sarita Joshi, Parinda A. Mehta, Stella M. Davies, Michael B. Jordan, Jack J. Bleesing, Alexandra H. Filipovich

Blood (2010) 116 (26): 5824–5831.

https://doi.org/10.1182/blood-2010-04-282392

Published: 2010

Includes: Supplemental data

NARROW

Emapalumab therapy for hemophagocytic lymphohistiocytosis prior to reduced-intensity transplantation improves chimerism

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Long-Term Outcome of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1) Using an Enhancer-Deleted Self-Inactivating Gammaretroviral Vector

Quercetin ameliorates XIAP deficiency–associated hyperinflammation

Peri-Transplant Alemtuzumab Levels Predict Risk of Secondary Graft Failure and Inversely Impact CXCL9 Levels after RIC HCT (A Correlative Biology Study to BMT-CTN 1204 RICHI)

T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

A Multi-Center Case Series, Systematic Review and Meta-Analysis of Neonatal Hemophagocytic Lymphohistiocytosis

Pediatric hemophagocytic lymphohistiocytosis

Neutropenia Is an Under-Recognized Finding in Pediatric Primary Immunodeficiency Diseases: An Analysis of the United States Immunodeficiency Network Registry

Treatment Dilemmas in Asymptomatic Children with Primary Haemophagocytic Lymphohistiocytosis

HIF1A Is a Critical Downstream Mediator for Hemophagocytic Lymphohistiocytosis

Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH

Precision Dosing of Alemtuzumab: Population Pharmacokinetic Modeling in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Non-Malignant Diseases

JAK1/2 Inhibition As a Salvage Therapy for Steroid Refractory Acute and Chronic Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients

Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT

Accuracy of flow cytometric perforin screening for detecting patients with FHL due to PRF1 mutations

Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes

Hypomorphic mutations in PRF1 , MUNC13-4 , and STXBP2 are associated with adult-onset familial HLH

Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only